Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1993 11
1994 5
1995 7
1996 40
1997 43
1998 49
1999 62
2000 123
2001 119
2002 165
2003 209
2004 239
2005 265
2006 273
2007 340
2008 279
2009 274
2010 275
2011 269
2012 314
2013 319
2014 314
2015 263
2016 291
2017 279
2018 254
2019 256
2020 246
2021 261
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

5,302 results
Results by year
Filters applied: . Clear all
Page 1
Tremor.
Louis ED. Louis ED. Continuum (Minneap Minn). 2019 Aug;25(4):959-975. doi: 10.1212/CON.0000000000000748. Continuum (Minneap Minn). 2019. PMID: 31356289 Review.
Topiramate: Comprehensive profile.
Khalil NY, AlRabiah HK, Al Rashoud SS, Bari A, Wani TA. Khalil NY, et al. Profiles Drug Subst Excip Relat Methodol. 2019;44:333-378. doi: 10.1016/bs.podrm.2018.11.005. Epub 2019 Jan 14. Profiles Drug Subst Excip Relat Methodol. 2019. PMID: 31029222
Topiramate, 2,3:4,5-di-O-isopropylidene-beta-d-fructopyranose sulfamate, is a potent antiepileptic drug with a broad spectrum of activity. ...The weight loss observed with the use of topiramate in obese, epileptic patients, afforded the approval of this drug as an a
Topiramate, 2,3:4,5-di-O-isopropylidene-beta-d-fructopyranose sulfamate, is a potent antiepileptic drug with a broad spectrum of acti
Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review.
Manhapra A, Chakraborty A, Arias AJ. Manhapra A, et al. J Addict Med. 2019 Jan/Feb;13(1):7-22. doi: 10.1097/ADM.0000000000000443. J Addict Med. 2019. PMID: 30096077 Review.
: Topiramate is a non-benzodiazepine anticonvulsant medication with multi-faceted pharmacologic action. ...Early pharmacogenetic studies raise the intriguing possibility of identifying patients likely to respond to topiramate using genetic testing, and initial studi …
: Topiramate is a non-benzodiazepine anticonvulsant medication with multi-faceted pharmacologic action. ...Early pharmacogenetic stud …
Topiramate in Migraine Prevention: A 2016 Perspective.
Silberstein SD. Silberstein SD. Headache. 2017 Jan;57(1):165-178. doi: 10.1111/head.12997. Epub 2016 Nov 30. Headache. 2017. PMID: 27902848 Review.
Its efficacy in chronic migraine is not improved by the addition of propranolol. Topiramate's ability to prevent progression from high-frequency episodic migraine to chronic migraine remains unclear. ...Even though topiramate's long half-life would see …
Its efficacy in chronic migraine is not improved by the addition of propranolol. Topiramate's ability to prevent progression f …
Current and emerging evidence-based treatment options in chronic migraine: a narrative review.
Agostoni EC, Barbanti P, Calabresi P, Colombo B, Cortelli P, Frediani F, Geppetti P, Grazzi L, Leone M, Martelletti P, Pini LA, Prudenzano MP, Sarchielli P, Tedeschi G, Russo A; Italian chronic migraine group. Agostoni EC, et al. J Headache Pain. 2019 Aug 30;20(1):92. doi: 10.1186/s10194-019-1038-4. J Headache Pain. 2019. PMID: 31470791 Free PMC article. Review.
FINDINGS: Patients with chronic migraine require prophylactic therapy to reduce the frequency of migraine attacks, but the only currently available evidence-based prophylactic treatment options for chronic migraine are topiramate and onabotulinumtoxinA. Improved prophylact …
FINDINGS: Patients with chronic migraine require prophylactic therapy to reduce the frequency of migraine attacks, but the only currently av …
Management of Alternating Hemiplegia of Childhood: A Review.
Samanta D. Samanta D. Pediatr Neurol. 2020 Feb;103:12-20. doi: 10.1016/j.pediatrneurol.2019.10.003. Epub 2019 Nov 1. Pediatr Neurol. 2020. PMID: 31836335 Review.
Disease-modifying therapy of alternating hemiplegia of childhood does not exist, and several agents such as benzodiazepines, flunarizine, topiramate, ketogenic diet, triheptanoin, steroid, amantadine, memantine, aripiprazole, oral ATP, coenzyme Q, acetazolamide, dextrometh …
Disease-modifying therapy of alternating hemiplegia of childhood does not exist, and several agents such as benzodiazepines, flunarizine, …
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak YJ, Lee SY. Tak YJ, et al. Curr Obes Rep. 2021 Mar;10(1):14-30. doi: 10.1007/s13679-020-00422-w. Epub 2021 Jan 6. Curr Obes Rep. 2021. PMID: 33410104 Free PMC article. Review.
RECENT FINDINGS: Recent meta-analyses of new anti-obesity drugs and their weight-loss efficacy have shown that the overall placebo-subtracted weight reduction (%) for at least 12 months ranged from 2.9 to 6.8% for the following drugs: phentermine/topiramate (6.8%), liraglu …
RECENT FINDINGS: Recent meta-analyses of new anti-obesity drugs and their weight-loss efficacy have shown that the overall placebo-subtracte …
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F; EURAP Study Group. Tomson T, et al. Lancet Neurol. 2018 Jun;17(6):530-538. doi: 10.1016/S1474-4422(18)30107-8. Epub 2018 Apr 18. Lancet Neurol. 2018. PMID: 29680205 Free article.
The primary objective was to compare the risk of major congenital malformations assessed at 1 year after birth in offspring exposed prenatally to one of eight commonly used antiepileptic drugs (carbamazepine, lamotrigine, levetiracetam, oxcarbazepine, phenobarbital, phenytoin, …
The primary objective was to compare the risk of major congenital malformations assessed at 1 year after birth in offspring exposed prenatal …
Current role of carbamazepine and oxcarbazepine in the management of epilepsy.
Beydoun A, DuPont S, Zhou D, Matta M, Nagire V, Lagae L. Beydoun A, et al. Seizure. 2020 Dec;83:251-263. doi: 10.1016/j.seizure.2020.10.018. Epub 2020 Dec 14. Seizure. 2020. PMID: 33334546 Review.
Despite a dramatic increase in treatment options over the past 30 years, it still ranks fourth in the world's disease burden. There are now close to 30 antiepileptic drugs (AEDs), with more than two thirds introduced to the market after carbamazepine (CBZ) and one third af …
Despite a dramatic increase in treatment options over the past 30 years, it still ranks fourth in the world's disease burden. There a …
Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
Palpacuer C, Duprez R, Huneau A, Locher C, Boussageon R, Laviolle B, Naudet F. Palpacuer C, et al. Addiction. 2018 Feb;113(2):220-237. doi: 10.1111/add.13974. Epub 2017 Sep 20. Addiction. 2018. PMID: 28940866 Free article.
DESIGN: Systematic review with direct and network meta-analysis of double-blind randomized controlled trials (RCTs) assessing the efficacy of nalmefene, naltrexone, acamprosate, baclofen or topiramate in non-abstinent adults diagnosed with alcohol dependence or AUDs. ...CO …
DESIGN: Systematic review with direct and network meta-analysis of double-blind randomized controlled trials (RCTs) assessing the efficacy o …
5,302 results